Fundraising Fox

Frontier Medicines

South San Francisco, US · Founded 2018 · Delaware corporation · 10 known investors

frontiermeds.com ↗

Frontier Medicines is a drug discovery company that combines chemoproteomics and AI to develop covalent small-molecule therapeutics against difficult-to-drug protein targets. Its platform maps the human proteome for covalency to pursue precision medicines in areas such as oncology and immunology.

AI & Machine LearningBiotechDeep Tech

Founders & leadership

Frontier Medicines was founded in 2018 by Chris Varma, Ph.D. and Chris Varma.

CVChris Varma, Ph.D.
Chris Varma, Ph.D.Co-founder
CVChris Varma
Chris VarmaCo-founder, Chairman and CEO
JW
Jim WinklerExecutive
JH
Johannes Hermann, Ph.D.Executive
KWKevin Webster
Kevin WebsterExecutive
GC
Gregory ChowExecutive

Board

JNJanwillem Naesens
Janwillem NaesensBoard directorManaging Partner at Droia Ventures
CW
Cameron WheelerBoard director
LELuke Evnin
Luke Evninin𝕏Board directorAdvisor at MPM BioImpact
OL
Othman LarakiBoard director

Investors · 10

Berkeley CatalystBerkeley
DCVC (Data Collective)Palo Alto · $5M – $25M
Droia VenturesLeuven · $540K
MPM BioImpactBoston · $1M – $15M
RA CapitalBoston
DCVC BioreportedPalo Alto
Deerfield Management CompanyreportedNew York

Also in the syndicate · 3

DeerfieldGalapagosGalapagos NV

Funding

SEC filings, press & company announcements

$235.5M disclosed across 3 of 5 rounds · 2019–2025

▶$88.5MraisedJul 2021 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jim WinklerExecutive Officer
  • Janwillem NaesensDirector
  • Johannes Hermann, Ph.D.Executive Officer
  • Kevin WebsterExecutive Officer
  • Cameron WheelerDirector
  • Luke EvninDirector
  • Gregory ChowExecutive Officer
  • Chris Varma, Ph.D.Executive Officer, Director
  • Othman LarakiDirector
Offering amount
$88.5M
Amount sold
$88.5M
First sale
Jun 2021
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$67MraisedNov 2020 · 31 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Chris Varma, Ph.D.Executive Officer, Director
  • Luke EvninDirector
  • Johannes Hermann, Ph.D.Executive Officer
  • Othman LarakiDirector
  • Janwillem NaesensDirector
  • Cameron WheelerDirector
  • Jim WinklerExecutive Officer
  • Kevin WebsterExecutive Officer
Offering amount
$67M
Amount sold
$67M
First sale
Apr 2019
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Frontier Medicines went on to found or lead other companies.

Luke EvninDirectorFounded Mpmcapital +1Kristina NebelSenior Executive AssistantFounded Walking Fish Therapeutics

Competitors · 1

by search overlap
Bioworld32 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Companies competing with Frontier Medicines for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Clinical-Stage Pipeline | Frontier Medicinesfrontiermeds.com · Aug 2025Frontier Medicines Raises $80M in Series C Funding | Precision Medicine Onlineprecisionmedicineonline.com · Feb 2024Frontier Medicines Raises $80M in Series C, Targets Amgen and BMS in KRAS - BioSpacebiospace.com · Feb 2024Frontier CEO weathers 'hardest financing' ever to raise $80Mfiercebiotech.com · Feb 2024Frontier Medicines Raises $88.5 Million to Advance Chemoproteomics Program - BioSpacebiospace.com · Jul 2021Frontier Medicines Raises $88.5 Million Series B Financing to Advance Precision Oncology and Targeted Protein Degradation Pipelineglobenewswire.com · Jul 2021Deerfield x Frontier Medicines – studying investment decisionsaxial.substack.com · Feb 2020

Frequently asked questions

What does Frontier Medicines do?
Frontier Medicines is a drug discovery company that combines chemoproteomics and AI to develop covalent small-molecule therapeutics against difficult-to-drug protein targets. Its platform maps the human proteome for covalency to pursue precision medicines in areas such as oncology and immunology.
Who founded Frontier Medicines?
Frontier Medicines was founded by Chris Varma, Ph.D., Chris Varma in 2018.
Who are Frontier Medicines's investors?
Frontier Medicines's investors include Berkeley Catalyst, DCVC (Data Collective), Droia Ventures, MPM BioImpact, RA Capital, DCVC Bio, Deerfield Management Company.
How much funding has Frontier Medicines raised?
Frontier Medicines has disclosed $235.5M raised across 3 of its 5 known rounds.
Where is Frontier Medicines headquartered?
Frontier Medicines is headquartered in South San Francisco, US.